BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26700818)

  • 1. PKCδ activated by c-MET enhances infiltration of human glioblastoma cells through NOTCH2 signaling.
    Hwang E; Yoo KC; Kang SG; Kim RK; Cui YH; Lee HJ; Kim MJ; Lee JS; Kim IG; Suh Y; Lee SJ
    Oncotarget; 2016 Jan; 7(4):4890-902. PubMed ID: 26700818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment involved in FPR1 expression by human glioblastomas.
    Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM
    J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.
    Hara K; Kageji T; Mizobuchi Y; Kitazato KT; Okazaki T; Fujihara T; Nakajima K; Mure H; Kuwayama K; Hara T; Nagahiro S
    Cancer Lett; 2015 Jan; 356(2 Pt B):496-505. PubMed ID: 25301448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback.
    Kim RK; Suh Y; Hwang E; Yoo KC; Choi KS; An S; Hwang SG; Kim IG; Kim MJ; Lee HJ; Lee SJ
    Oncogene; 2015 Nov; 34(46):5749-59. PubMed ID: 25746003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
    Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
    Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner.
    Lindemann C; Marschall V; Weigert A; Klingebiel T; Fulda S
    Neoplasia; 2015 Jun; 17(6):481-9. PubMed ID: 26152356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
    Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
    Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radixin knockdown by RNA interference suppresses human glioblastoma cell growth in vitro and in vivo.
    Qin JJ; Wang JM; Du J; Zeng C; Han W; Li ZD; Xie J; Li GL
    Asian Pac J Cancer Prev; 2014; 15(22):9805-12. PubMed ID: 25520109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
    Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
    Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Yamada K; Oikawa T; Kizawa R; Motohashi S; Yoshida S; Kumamoto T; Saeki C; Nakagawa C; Shimoyama Y; Aoki K; Tachibana T; Saruta M; Ono M; Yoshida K
    Cancer Res; 2021 Jan; 81(2):414-425. PubMed ID: 33318039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
    Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
    Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
    J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells.
    Wu J; Feng X; Zhang B; Li J; Xu X; Liu J; Wang X; Wang J; Tong X
    J Neurooncol; 2014 Oct; 120(1):33-41. PubMed ID: 25048528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.